|
Showing 1 - 5 of
5 matches in All Departments
A panel of international psychiatrists, neurologists, clinical
psychologists, and neuropsychiatrists review for the clinical
neurologist those aspects of psychiatry that impact the management
of neurological disorders. On the one hand, the authors illuminate
the neurological aspects of such psychiatric disorders as
depression, anxiety disorders, schizophrenia, hysteria, catatonia,
addictions, and personality disorders. On the other hand, they also
explain in detail the psychiatric evaluation of the neurological
patient and discuss the behavioral aspects of the major
neurological disorders, including psychiatric complications of
dementia and stroke, neuromuscular disorders, the psychiatric
aspects of Parkinson's disease, epilepsy, Huntington's disease,
Tourette's syndrome, and multiple sclerosis. Comprehensive and
timely, Psychiatry for Neurologists helps to close the artificial
gap separating neurology and psychiatry so that neurologists feel
comfortable managing the psychiatric aspects of the neurological
disorders they treat.
A panel of international psychiatrists, neurologists, clinical
psychologists, and neuropsychiatrists review for the clinical
neurologist those aspects of psychiatry that impact the management
of neurological disorders. On the one hand, the authors illuminate
the neurological aspects of such psychiatric disorders as
depression, anxiety disorders, schizophrenia, hysteria, catatonia,
addictions, and personality disorders. On the other hand, they also
explain in detail the psychiatric evaluation of the neurological
patient and discuss the behavioral aspects of the major
neurological disorders, including psychiatric complications of
dementia and stroke, neuromuscular disorders, the psychiatric
aspects of Parkinson's disease, epilepsy, Huntington's disease,
Tourette's syndrome, and multiple sclerosis. Comprehensive and
timely, Psychiatry for Neurologists helps to close the artificial
gap separating neurology and psychiatry so that neurologists feel
comfortable managing the psychiatric aspects of the neurological
disorders they treat.
'Parkinson's disease (PD) is a chronic and progressive disease that
affects as many as one million people in the United States alone.
Although many patients and families are aware of the physical
challenges that accompany Parkinson s disease, few are prepared to
deal with the common behavioral issues that impact their quality of
life. Behavior problems in PD are not always catastrophic, but they
are common. It is estimated that 65-90% of PD patients experience
some level of depression, anxiety, dementia, hallucinations,
paranoid delusions, sleep disorders, and other behavioral disorders
that affect everyone involved. Written in easy-to-read language,
Making the Connection Between Brain and Behavior is the only book
that focuses entirely on an area that many doctors overlook, an
area that often causes the most problems and can be the most
treatable. The self-contained chapters will help readers
understand, address, and cope with common behavioral issues, as
well as provide guidance on ways to communicate with the healthcare
team.
Medications that may produce movement disorders are widely used.
The resulting disorders are often highly disconcerting for the
patient and their relatives, especially when the connection between
medication and disorder is not recognized. However, ascribing an
adverse drug effect to medication exposure is often difficult,
especially when the side effect is rare. Covering various drugs -
including the major classes of medications working primarily on the
brain, specifically antipsychotics and antidepressants - this
all-encompassing review of medication-induced movement disorders
aids early recognition and improved treatment. The problem of what
to do when the offending medication cannot be reduced is also
reviewed. It discusses the best options for evaluation and
treatment, including medical imaging and deep brain stimulation,
and guides the clinician in managing the disorder, making this a
vital reference for medical specialists and consultants in
neurology and neuropharmacology and any clinician seeing patients
on medications crossing the blood-brain barrier.
Medications that may produce movement disorders are widely used.
The resulting disorders are often highly disconcerting for the
patient and their relatives, especially when the connection between
medication and disorder is not recognized. However, ascribing an
adverse drug effect to medication exposure is often difficult,
especially when the side effect is rare. Covering various drugs -
including the major classes of medications working primarily on the
brain, specifically antipsychotics and antidepressants - this
all-encompassing review of medication-induced movement disorders
aids early recognition and improved treatment. The problem of what
to do when the offending medication cannot be reduced is also
reviewed. It discusses the best options for evaluation and
treatment, including medical imaging and deep brain stimulation,
and guides the clinician in managing the disorder, making this a
vital reference for medical specialists and consultants in
neurology and neuropharmacology and any clinician seeing patients
on medications crossing the blood-brain barrier.
|
|